Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESPRODUCTOS SOLARES
Con la llegada del verano y las elevadas temperaturas en el mes de junio, la venta de productos solares ha aumentado, alcanzando una facturación mensual de 43.7 M€, un 51,66% más que en el mes de mayo. Si esta comparación se realiza con los mismos periodos del año anterior, se ve que el crecimiento actual de mayo a junio ha sido más abrupto, siendo en el 2022 de 3,35%.
Desde julio 2022 hasta junio 2023, los productos solares han facturado 242.2 M€, lo que supone un 9,11% más que el acumulado entre julio 2021 y junio 2022.
PRODUCTOS PARA PICADURAS DE INSECTOS
Debido a las elevadas temperaturas y la mayor exposición al aire libre por la llegada de las vacaciones y los campamentos, se ha observado un incremento de 257% en la venta de los repelentes de insectos comparadas con las del mes de mayo.
Durante el mes de junio se ha facturado 8 M€, alcanzando 28.6 M€ entre julio 2022 y junio 2023, un 10,69% más en comparación con julio 2021-junio 2022.
TIRAS Y APÓSITOS
Con el aumento de las actividades al aire libre, se ha incrementado la venta de tiras y apósitos para la curación de heridas.
La facturación de estos productos en el mes de junio es de 6.6 M€, un 15,21% más que en el mes anterior.
Entre julio 2022 y junio 2023, se ha facturado 60 M€, un 5,11% más respecto al acumulado entre julio 2021 y junio 2022.
IPC
El indicador de precios de Consumer Health mantiene su tendencia de moderación, al alcanzar 5% en junio. Además, tanto el IPC como el IPC subyacente continúan disminuyendo, situándose en el mes de junio en 1,9% y 5,9% respetivamente.